Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT05758376 Recruiting - Mental Illness Clinical Trials

Recovery Bridge: A Peer Facilitated Intervention to Help Bridge the Transition From Psychiatric Inpatient Hospitalized to Living in the Community

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The time following discharge from psychiatric hospitalization is a high-risk period and has been associated with a range of negative outcomes including high rates of hospital readmission and suicide. The purpose of this proposal is to: 1) create a Peer Specialist facilitated intervention, called Recovery Bridge, designed to facilitate the transition from inpatient psychiatric hospitalization to community living; 2) examine feasibility, fidelity, and acceptability; and preliminarily explore the impact of the intervention on: a) readmission rates and connection to outpatient care compared to a control group identified from administrative data; and b) change in recovery and quality of life measures over time in the intervention participants. Results from the proposed open pilot trial will set the stage for next steps including a larger effectiveness trial followed by a possible hybrid-I effectiveness/implementation trial to inform future dissemination and implementation of the intervention more broadly across the VA.

NCT ID: NCT05758285 Recruiting - Mental Disorders Clinical Trials

Using Responsible Artificial Intelligence (AI) to Predict Online Therapy Outcome and Engagement

Start date: March 1, 2023
Phase:
Study type: Observational

This study is to develop AI-based models for the personalised prediction of treatment engagement and treatment outcomes in patients engaging in digital psychotherapy. A large, real-world dataset of patients in a digital psychotherapy program will be used to train AI algorithms. Responsible AI algorithms will be developed by describing, accounting for, and mitigating bias due to severity of mental disturbances in AI-based models, in addition to considering bias due to other sensitive attributes, such as gender, ethnicity, and socio-demographic status.

NCT ID: NCT05757206 Recruiting - Clinical trials for REM Sleep Behavior Disorder (iRBD)

The Syn-Sleep Study

Start date: September 15, 2022
Phase:
Study type: Observational

In collaboration with approximately 8 centers that specialize in iRBD we will recruit a total of 80 individuals for the study. All subjects will be enrolled into a 2-year longitudinal study where skin biopsies will be performed at 3 sites on each patient at 12-month intervals (baseline, year 1, year 2). Plasma blood collection will be performed at 12-month intervals (baseline, year 1, year 2). Detailed quantified examination, cognitive evaluation, medical history, and questionnaires will be performed at each visit. Additional biomarker, imaging and clinical information (if available) will be obtained for the purpose of determining phenoconversion to clinically apparent synucleinopathy. Subjects enrolled in the study will have baseline evaluations and follow up visits at 12 and 24 months to define any changes to clinical diagnosis (clinical phenoconversion). Skin biopsies will be repeated at the 12- and 24-month follow up visits to determine the rate of P-SYN accumulation over time and the rates of nerve fiber degeneration within punch skin biopsies.

NCT ID: NCT05757128 Recruiting - Psychosis Clinical Trials

Optimizing Mental Health for Young People at Clinical High Risk for Psychosis (CHR)

Start date: August 24, 2023
Phase: N/A
Study type: Interventional

This proposal aims to adapt an evidence-based comprehensive psychosocial and mental health support program, the Optimal Health Program (OHP), to improve functioning, reduce distress, and build resiliency in youth who are at clinical risk of developing psychosis (CHR). The main aims of the studies are 1). To adapt an existing, effective, validated psychological intervention for use in young people with CHR; 2). To evaluate the acceptability of OHP and the feasibility of conducting a clinical trial of OHP in individuals with CHR; 3). To assess the preliminary efficacy of OHP in enhancing resiliency, reducing depression and anxiety, and improving functioning in individuals with CHR in a single-arm exploratory clinical trial. Participants will be delivered OHP intervention over 12-weeks. Measures will be completed at study entry and repeated immediately post-treatment at 12-weeks.

NCT ID: NCT05756855 Recruiting - Schizophrenia Clinical Trials

Young Adults With Violent Behavior During Early Psychosis

Start date: March 19, 2024
Phase: N/A
Study type: Interventional

This study aims to provide an evidence-based behavioral intervention to reduce violent behavior for individuals experiencing early psychosis.

NCT ID: NCT05753423 Recruiting - Clinical trials for Mental Health Disorder

Impact of Maternal Mental Health on the Oral Health Status and Oral Health-related Quality of Life of Their Children

Start date: May 8, 2022
Phase:
Study type: Observational

Dental caries is a complex multifactorial disease that is strongly related to and influenced by the children's dietary habits, sugar intake, salivary flow, salivary fluoride level, and preventive behaviors. Based on the literature, other factors can affect child dental caries including the influence of social factors, such as the family environment. To avoid suffering from dental caries, preventive oral hygiene practices beginning in childhood are crucial. However, parents are the primary providers of oral health care for their children and they generally play a pivotal role in the overall health and oral health of both children and adolescents. Therefore, this study aims to investigate the impact of maternal mental health in the form of depression, anxiety, or stress and their perceived social support on the oral health status and OHRQoL of their children.

NCT ID: NCT05738486 Recruiting - Dementia Clinical Trials

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

Start date: February 28, 2023
Phase: Phase 3
Study type: Interventional

This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD) and explore participant characteristics that might predict risk of ARIA.

NCT ID: NCT05728138 Recruiting - Clinical trials for Self Harm, First Episode Psychosis

Psychosocial Intervention for Suicidal Ideation in Individuals With FEP: A Feasibility Trial

CMAP-FEP
Start date: November 1, 2023
Phase: N/A
Study type: Interventional

To check the feasibility and acceptability of Culturally adapted Cognitive Behavioral Therapy for Psychosis (CaCBTp) and Culturally Adapted Manual Assisted Brief Psychological Intervention for Self-harm (CMAP), which we have provisionally called (CMAP Plus) for individuals experiencing Suicidal Ideation (SI) in First Episode Psychosis (FEP).

NCT ID: NCT05723328 Recruiting - Bipolar Disorder Clinical Trials

Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma

Start date: April 25, 2023
Phase: N/A
Study type: Interventional

This study will use a systematic music therapy intervention on patients with mental illness trying to help them with their internalized stigma.

NCT ID: NCT05719116 Recruiting - Psychosis Clinical Trials

A Combined Aerobic and Resistance Training Program for Adults With Psychotic Disorders

TREPP
Start date: November 23, 2022
Phase: N/A
Study type: Interventional

The study is a feasibility study of a combined high intensity aerobic and strenght exercise program for persons with psychotic disorders. The feasibility of the protocol will be investigated, in addition to the participants subjective experience with the participation.